Eur Rev Med Pharmacol Sci 2018; 22 (3): 578-579
DOI: 10.26355/eurrev_201802_14267

Mediation of inflammation, obesity and fatty liver disease by advanced glycation endoproducts

S. Milione, M. Di Caterino, L. Monaco, L. Rinaldi

Department of Medical, Surgical, Neurological, Metabolic and Geriatric Sciences, Campania University “Luigi Vanvitelli”, Caserta, Italy. luca.rinaldi@unicampania.it

Free PDF Download

To cite this article

S. Milione, M. Di Caterino, L. Monaco, L. Rinaldi
Mediation of inflammation, obesity and fatty liver disease by advanced glycation endoproducts

Eur Rev Med Pharmacol Sci
Year: 2018
Vol. 22 - N. 3
Pages: 578-579
DOI: 10.26355/eurrev_201802_14267

Keywords Related articles:

  1. Mediation of inflammation, obesity and fatty liver disease by advanced glycation endoproducts
  2. Influence of ala54thr polymorphism of fatty acid-binding protein 2 on histological alterations and insulin resistance of non alcoholic fatty liver disease
  3. Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial
  4. The epidemiology of non-alcoholic fatty liver disease and its connection with cardiovascular disease: role of endothelial dysfunction
  5. Nonalcoholic fatty liver disease: defining a common problem